THRIXEN PTE. LTD.

Rapid Mulitplex Diagnostic Platform

Operating in medtech, biotech based in Singapore, THRIXEN PTE. LTD. was founded in 2020.

Profile

Thrixen aims to revolutionize the diagnostic field by making diagnostic tests easily accessible, simple to operate, and, importantly, able to detect multiple biomarkers (multiplex) for a more accurate test result that provides informative and clinically relevant data.

To achieve this vision, Thrixen has developed a set of technologies that:

I. Replace the incumbent antibody-based immunoassay technology with a protein engineering platform to produce binder proteins with superior performance, stability, and multiplex-ability vs antibodies

II. Allows tests to be conducted simply and rapidly at a widely affordable cost using the unique vertical flow cellulose diagnostic testing platform.

III. Allow for tests to be performed outside of laboratory using the portable reader compatible to the vertical flow testing format.

As a business in medtech, biotech, THRIXEN PTE. LTD. is listed here with the public details available about it.

Singapore is where the company is located.

It is recorded at the Startup SG directory startup stage.

Its team size is recorded as 1 - 10 employees.

Website: www.thrixen.com